Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Tuesday, June 10, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
admin
-
June 4, 2025
Latest Pharma-News
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
admin
-
June 4, 2025
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
admin
-
April 23, 2020
0
Latest Pharma-News
Confirmation of COVID-19 in Two Pet Cats in New York
admin
-
April 23, 2020
0
Latest Pharma-News
Hard fought gains in immunization coverage at risk without critical health services, warns WHO
admin
-
April 23, 2020
0
Latest Pharma-News
Novartis announces new Mayzent® (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis...
admin
-
April 22, 2020
0
Latest Pharma-News
Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments
admin
-
April 22, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection
admin
-
April 22, 2020
0
Latest Pharma-News
Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19
admin
-
April 22, 2020
0
Latest Pharma-News
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
admin
-
April 22, 2020
0
Latest Pharma-News
UN agencies issue urgent call to fund the global emergency supply system to fight COVID-19
admin
-
April 22, 2020
0
Latest Pharma-News
New study to explore the effects of social distancing launched online
admin
-
April 21, 2020
0
Latest Pharma-News
Five Oxford COVID-19 projects receive UKRI funding
admin
-
April 21, 2020
0
Latest Pharma-News
Alembic Pharmaceuticals announces USFDA Tentative Approval for Alcaftadine Ophthalmic Solution, 0.25%.
admin
-
April 21, 2020
1
1
...
120
121
122
...
145
Page 121 of 145
- Advertisment -
Most Read
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
June 4, 2025
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
June 4, 2025
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025